Ambee Pharmaceuticals Limited

184/1 Tejgaon Industrial Area, Dhaka 1208 URL : www. ambeepharma.com First Quarter Financial Statement (Un-audited)

Statement of Financial Position as at 31st March 2013 (Unaudited) Taka in '000

Statement of Cash Flows For the period from January 01, 2013 to March 31, 2013 (Unaudited) Taka in '000

31st March 2013 ASSETS Non-Current Assets: Property, Plant & Equipment Plant & Machinery of Injectable Unit (un-installed) Current Assets: Inventories Trade Receivable Advances, Deposits and Pre-payments Cash and Cash Equivalents Total Assets EQUITY AND LIABILITIES: Capital and Reserves: Share Capital Tax-Holiday Reserve Retained Earnings-As per statement of changes in equity Non Current Liabilities: Deffered Tax Liabilities Current Liabilities and Provisions: Bank Loans (Secured) Creditors and Other Payables Total Equity and Liabilities Net Asset Value per share (NAV) Statement of Comprehensive Income For the period ended 31 st March 2013 (Unaudited) 50,675 49,457 1,218 229,443 117,674 48,721 54,630 8,418 280,118 53,609 20,000 5,134 28,475

31st Dec.2012

Item 1st Quarter 2013 Jan-March 2013 1st Quarter 2012 Jan-March 2012

51,701 50,483 1,218 227,132 119,873 42,992 56,080 8,187 278,833 52,279 20,000 5,134 27,145

Cash Flows from Operating Activities : Collection from turnover Payments for Costs and Expenses Income-tax paid/deducted at source Interest on short term borrowing Net cash generated from Operating Activities : Cash Flows from Investing Activities : Acquisition of Fixed Assets Cash Generated from Investment Activities: Cash Flows from Financing Activities : Loans (paid)/received Cash Generated From Financial Activities: Net Cash inflows/ (outflows) for the period Opening Cash and Bank balances Closing Cash and Bank balances Net Operating Cash Flow per share 77,740 (68,479) (793) (3,442) 5,026 60,431 (53,900) (254) (3,331) 2,946

(203) (203) 4,823 3,595 8,418 2.51

(1,481) (1,481) 1,465 2,130 3,595 1.47

8,054 218,455 107,189 111,266 280,118 26.80

8,054 218,500 107,392 111,108 278,833 26.14

Statement of Changes in Equity For the period from January 01, 2013 to March 31, 2013 (Unaudited) Taka in '000 Taka '000

1st Quarter 2013 1st Quarter 2012 Jan-March 2013 Jan-March 2012 Revenue (Turnover) from Net Sales Cost and Expenses : Cost of Goods Sold Administrative Expenses Marketing and Selling Expenses Financial Expenses Total Costs and Expenses Net Profit before income-tax Provision for income -tax Net Profit after income-tax Earning Per Share (EPS) 72,011 69,146

Particular As at January 01,2013 Net Profit (for 1st Quarter Ended on March 31, 2013) At 31st March 2013

Share Capital 20,000

Tax Holiday Reserve 5,134

Retained Earning 27,145 1,330

Total 52,279 1,330

30,694 3,247 32,794 3,442 70,177 1,834 504 1,330 0.66

29,334 4,162 30,570 3,331 67,397 1,749 481 1,268 0.63

20,000

5,134

28,475

53,609

Statement of Changes in Equity For the period from January 01, 2012 to March 31, 2012 (Unaudited) Taka '000 Tax Holiday Reserve 5,134 Retained Earning 25,275 1,268

Particular As at January 01,2012 Net Profit (for 1st Quarter Ended on March31, 2012) At 31st March 2012

Share Capital 20,000

Total 50,409 1,268

20,000

5,134

26,543

51,677

Sd/(Naureen Aziz Mohammad Bhai) Managing Director

Sd/(A.K.M Khairul Aziz) Acting Chief Financial Officer

(2.73) 1.16 5.32 5.22

4.30 97.68 2.32 0.64

76.00 736.00 80.00 21.60